{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:49:15Z","timestamp":1789645755270,"version":"4.0.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplastic proliferations showing different morphological features, immunophenotype, molecular background, clinical presentation, and outcome. They can virtually originate in every organ of the human body and their classification is not uniform among different sites. Indeed, as they have historically been classified according to the organ in which they primarily arise, the different nomenclature that has resulted have created some confusion among pathologists and clinicians. Although a uniform terminology to classify neuroendocrine neoplasms arising in different systems has recently been proposed by WHO\/IARC, some issues remain unsolved or need to be clarified. In this review, we discuss the lights and shadows of the current WHO classifications used to define and characterize NENs of the pituitary gland, lung, breast and those of the head and neck region, and digestive and urogenital systems.<\/jats:p>","DOI":"10.1007\/s11154-020-09612-2","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T19:03:44Z","timestamp":1604948624000},"page":"527-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Classification of neuroendocrine neoplasms: lights and shadows"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2403","authenticated-orcid":false,"given":"Stefano","family":"La Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-7295","authenticated-orcid":false,"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"9612_CR1","doi-asserted-by":"crossref","unstructured":"Uccella 2021, Uccella S, La Rosa S, Volante M, Papotti M. Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol. 2018;29:150\u201368.","DOI":"10.1007\/s12022-018-9522-y"},{"issue":"Suppl 1","key":"9612_CR2","first-page":"113","volume":"31","author":"S Uccella","year":"2015","unstructured":"Uccella S, Sessa F, La Rosa S. Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turk Patoloji Derg. 2015;31(Suppl 1):113\u201327.","journal-title":"Turk Patoloji Derg"},{"key":"9612_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/modpathol.2016.220","volume":"30","author":"M Jesinghaus","year":"2017","unstructured":"Jesinghaus M, Konukiewitz B, Keller G, Kloor M, Steiger K, Reiche M, et al. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Mod Pathol. 2017;30:610\u20139.","journal-title":"Mod Pathol"},{"key":"9612_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2016.150","volume":"30","author":"C Woischke","year":"2017","unstructured":"Woischke C, Schaaf CW, Yang HM, Vieth M, Veits L, Geddert H, et al. In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. Mod Pathol. 2017;30:95\u2013103.","journal-title":"Mod Pathol"},{"key":"9612_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","volume":"36","author":"S Yachida","year":"2012","unstructured":"Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36:173\u201384.","journal-title":"Am J Surg Pathol"},{"key":"9612_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331:1199\u2013203.","journal-title":"Science."},{"key":"9612_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ando.2019.04.010","volume":"80","author":"A Scarpa","year":"2019","unstructured":"Scarpa A. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. Ann Endocrinol. 2019;80:153\u20138.","journal-title":"Ann Endocrinol"},{"key":"9612_CR8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","volume":"9","author":"J George","year":"2018","unstructured":"George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun. 2018;9:1048.","journal-title":"Nat Commun"},{"key":"9612_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jtho.2019.05.003","volume":"14","author":"M Simbolo","year":"2019","unstructured":"Simbolo M, Barbi S, Fassan M, Mafficini A, Ali G, Vicentini C, et al. Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three Transcriptomic subtypes with specific genomic alterations. J Thorac Oncol. 2019;14:1651\u201361.","journal-title":"J Thorac Oncol"},{"key":"9612_CR10","volume-title":"WHO classification of tumors of the digestive system","author":"G Rindi","year":"2010","unstructured":"Rindi G, Arnold R, Bosman FT, Capella C, Klimstra DS, Kloppel G, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010."},{"key":"9612_CR11","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2015."},{"key":"9612_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152\u201360.","journal-title":"Ann Oncol"},{"key":"9612_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, et al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogeneous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 2015;39:683\u201390.","journal-title":"Am J Surg Pathol"},{"key":"9612_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000445165","volume":"104","author":"M Milione","year":"2017","unstructured":"Milione M, Maisonneuve P, Spada F, Pellegrinelli A, Spaggiari P, Albarello L, et al. The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology. 2017;104:85\u201393.","journal-title":"Neuroendocrinology."},{"key":"9612_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/14737159.2019.1595593","volume":"19","author":"G Pelosi","year":"2019","unstructured":"Pelosi G, Bianchi F, Hofman P, Pattini L, Str\u00f6bel P, Calabrese F, et al. Recent advances in the molecular landscape of lung neuroendocrine tumors. Expert Rev Mol Diagn. 2019;19:281\u201397.","journal-title":"Expert Rev Mol Diagn"},{"key":"9612_CR16","volume-title":"WHO classification of tumours of endocrine organs","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. Lyon: IARC; 2017."},{"key":"9612_CR17","unstructured":"Klimstra DS, Kl\u00f6ppel G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board editors. WHO classification of tumours, 5th edn. Digestive system tumours. Lyon: IARC; 2019. pp. 16\u20139."},{"key":"9612_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/his.14178","volume":"77","author":"S Uccella","year":"2020","unstructured":"Uccella S, La Rosa S. Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors. Histopathology. 2020;77:700\u201317. https:\/\/doi.org\/10.1111\/his.14178.","journal-title":"Histopathology."},{"key":"9612_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","volume":"27","author":"S La Rosa","year":"2016","unstructured":"La Rosa S, Sessa F, Uccella S. Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms. Endocr Pathol. 2016;27:284\u2013311.","journal-title":"Endocr Pathol"},{"key":"9612_CR20","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770\u201386.","journal-title":"Mod Pathol"},{"key":"9612_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59655-1","volume-title":"Histological typing of endocrine tumors. WHO international histological classification of tumors2nd ed","author":"E Solcia","year":"2000","unstructured":"Solcia E, Kl\u00f6ppel G, Sobin LH (in collaboration with 9 pathologist from 9 countries). Histological typing of endocrine tumors. WHO international histological classification of tumors2nd ed. Heidelberg: Springer-Verlag; 2000."},{"key":"9612_CR22","first-page":"798","volume":"19","author":"SL Asa","year":"1998","unstructured":"Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev. 1998;19:798\u2013827.","journal-title":"Endocr Rev"},{"key":"9612_CR23","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology Club proposal. Endocr Relat Cancer. 2017;24:C5\u20138.","journal-title":"Endocr Relat Cancer"},{"key":"9612_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N, et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 2013;126:123\u201335.","journal-title":"Acta Neuropathol"},{"key":"9612_CR25","doi-asserted-by":"crossref","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C. How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel). 2020;12:514.","DOI":"10.3390\/cancers12020514"},{"key":"9612_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, et al. A tale of pituitary adenomas: to NET or not to NET: pituitary society position statement. Pituitary. 2019;22:569\u201373.","journal-title":"Pituitary."},{"key":"9612_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11102-019-01015-0","volume":"23","author":"SL Asa","year":"2020","unstructured":"Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, et al. Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary. 2020;23:322\u20135.","journal-title":"Pituitary."},{"key":"9612_CR28","doi-asserted-by":"publisher","unstructured":"Ho KKY, Fleseriu M, Wass J, et al. The tale in evolution: clarity, consistency and consultation, not contradiction and confusion [published online ahead of print, 2020 Jan 7]. Pituitary. doi:https:\/\/doi.org\/10.1007\/s11102-019-01027-w, 23, 476, 477.","DOI":"10.1007\/s11102-019-01027-w"},{"key":"9612_CR29","first-page":"14","volume":"109","author":"S Uccella","year":"2017","unstructured":"Uccella S, Ottini G, Facco C, Maragliano R, Asioli S, Sessa F, et al. Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification Pathologica. 2017;109:14\u201330.","journal-title":"Diagnosis and classification Pathologica"},{"key":"9612_CR30","volume-title":"World Health Organization classification of Tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichart P, Reichart P, Sidransky D. World Health Organization classification of Tumours. Pathology & Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005."},{"key":"9612_CR31","volume-title":"WHO classification of head and neck tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. Lyon: IARC Press; 2017."},{"key":"9612_CR32","doi-asserted-by":"crossref","unstructured":"Yan J, Yu S, Jia C, Li M, Chen J. Molecular subtyping in pancreatic neuroendocrine neoplasms: new insights into clinical, pathological unmet needs and challenges [published online ahead of print. Biochim Biophys Acta Rev Cancer. 2020;2020.","DOI":"10.1016\/j.bbcan.2020.188367"},{"key":"9612_CR33","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1530\/ERC-20-0036","volume":"27","author":"G Rindi","year":"2020","unstructured":"Rindi G, Inzani F. Neuroendocrine neoplasm update: toward universal nomenclature. Endocr Relat Cancer. 2020;27:R211\u20138.","journal-title":"Endocr Relat Cancer"},{"key":"9612_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.oraloncology.2017.09.010","volume":"74","author":"M Turri-Zanoni","year":"2017","unstructured":"Turri-Zanoni M, Maragliano R, Battaglia P, Giovannardi M, Antognoni P, Lombardi D, et al. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 2017;74:21\u20139.","journal-title":"Oral Oncol"},{"key":"9612_CR35","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al. ENETS consensus conference participants. Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 2015;26:1604\u201320.","journal-title":"Ann Oncol"},{"key":"9612_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00428-016-2062-2","volume":"470","author":"A Fabbri","year":"2017","unstructured":"Fabbri A, Cossa M, Sonzogni A, Papotti M, Righi L, Gatti G, et al. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied. Virchows Arch. 2017;470:153\u201364.","journal-title":"Virchows Arch"},{"key":"9612_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031531","volume":"9","author":"S Naheed","year":"2019","unstructured":"Naheed S, Holden C, Tanno L, Jaynes E, Cave J, Ottensmeier CH, et al. The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9:e031531.","journal-title":"BMJ Open"},{"key":"9612_CR38","doi-asserted-by":"crossref","unstructured":"Pelosi G, Massa F, Gatti G, Righi L, Volante M, Birocco N, Maisonneuve P, Sonzogni A, Harari S, Albini A, Papotti M. Ki-67 evaluation for clinical decision in metastatic lung carcinoids: a proof of concept. Clin Pathol. 2019;12:2632010X19829259.","DOI":"10.1177\/2632010X19829259"},{"key":"9612_CR39","doi-asserted-by":"publisher","unstructured":"Milione M, Maisonneuve P, Grillo F, Mangogna A, Centonze G, Prinzi N, et al. Ki-67 index of 55% distinguishes two groups of bronchopulmonary pure and composite large cell neuroendocrine carcinomas with distinct prognosis. Neuroendocrinology. 2020. https:\/\/doi.org\/10.1159\/000508376.","DOI":"10.1159\/000508376"},{"key":"9612_CR40","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41379-018-0076-9","volume":"31","author":"AM Marchevsky","year":"2018","unstructured":"Marchevsky AM, Hendifar A, Walts AE. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Mod Pathol. 2018;31:1523\u201331.","journal-title":"Mod Pathol"},{"key":"9612_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00428-017-2177-0","volume":"471","author":"C Marchi\u00f2","year":"2017","unstructured":"Marchi\u00f2 C, Gatti G, Massa F, Bertero L, Filosso P, Pelosi G, et al. Distinctive pathological and clinical features of lung carcinoids with high proliferation index. Virchows Arch. 2017;471:713\u201320.","journal-title":"Virchows Arch"},{"key":"9612_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000495806","volume":"108","author":"A Kasajima","year":"2019","unstructured":"Kasajima A, Konukiewitz B, Oka N, Suzuki H, Sakurada A, Okada Y, et al. Clinicopathological profiling of lung carcinoids with a Ki67 index > 20. Neuroendocrinology. 2019;108:109\u201320.","journal-title":"Neuroendocrinology."},{"key":"9612_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00428-018-2307-3","volume":"472","author":"G Pelosi","year":"2018","unstructured":"Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, et al. Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Arch. 2018;472:567\u201377.","journal-title":"Virchows Arch"},{"key":"9612_CR44","doi-asserted-by":"publisher","unstructured":"Cros J, Th\u00e9ou-Anton N, Gounant V, Nicolle R, Reyes C, Humez S, et al. Specific genomic alterations in high grade pulmonary neuroendocrine tumours with carcinoid morphology. Neuroendocrinology. 2020. https:\/\/doi.org\/10.1159\/000506292.","DOI":"10.1159\/000506292"},{"key":"9612_CR45","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","volume":"10","author":"N Alcala","year":"2019","unstructured":"Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, et al. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun. 2019;10:3407.","journal-title":"Nat Commun"},{"key":"9612_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/2632010X19829259","volume":"12","author":"G Pelosi","year":"2019","unstructured":"Pelosi G, Massa F, Gatti G, Righi L, Volante M, Birocco N, et al. Ki-67 evaluation for clinical decision in metastatic lung carcinoids: a proof of concept. Clin Pathol. 2019;12:263.","journal-title":"Clin Pathol"},{"key":"9612_CR47","first-page":"24","volume":"73","author":"F Feyrter","year":"1963","unstructured":"Feyrter F, Hartmann G. Uber die carcinoide Wuchsform der Carcinoma mammae, insbesondere das Carcinoma Solidum (gelatinosum) mammae. Frankf Z Pathol. 1963;73:24\u201339.","journal-title":"Frankf Z Pathol"},{"key":"9612_CR48","first-page":"186","volume":"120","author":"G Bussolati","year":"1985","unstructured":"Bussolati G, Gugliotta P, Sapino A, Eusebi V. Lloyd RV Chromogranin reactive endocrine cells in argyrophilic carcinomas (\u201ccarcinoids\u201d) and normal tissue of the breast. Am J Pathol. 1985;120:186\u201392.","journal-title":"Am J Pathol"},{"key":"9612_CR49","first-page":"174","volume":"61","author":"M Papotti","year":"1989","unstructured":"Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol. 1989;61:174\u201388.","journal-title":"Semin Diagn Pathol"},{"key":"9612_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/01913129009032247","volume":"14","author":"C Capella","year":"1990","unstructured":"Capella C, Usellini L, Papotti M, Macri L, Finzi G, Eusebi V. Bussolati G Ultrastructural features of neuroendocrine differentiated carcinomas of the breast. Ultrastruct Pathol. 1990;14:321\u201334.","journal-title":"Ultrastruct Pathol"},{"key":"9612_CR51","doi-asserted-by":"publisher","unstructured":"Uccella S, Finzi G, Sessa F, La Rosa S. On the endless dilemma of neuroendocrine neoplasms of the breast: a journey through concepts and entities [published online ahead of print, 2020 Jul 2]. Endocr Pathol. 2020. https:\/\/doi.org\/10.1007\/s12022-020-09637-y.","DOI":"10.1007\/s12022-020-09637-y"},{"key":"9612_CR52","unstructured":"Rakha EA, Reis-Filho JS, Sasano H, Wu. Neuroendocrine neoplasms: introduction. In: WHO Classification of Tumours Editorial Board editors. Breast tumours, 5th Ed, vol. 2. Lyon: IARC; 2019. pp. 155."},{"key":"9612_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/path.4837","volume":"241","author":"C Marchi\u00f2","year":"2017","unstructured":"Marchi\u00f2 C, Geyer FC, Ng CKY, Piscuoglio S, de Filippo MR, Cupo M, et al. The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol. 2017;241:405\u201319.","journal-title":"J Pathol"},{"key":"9612_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1634\/theoncologist.2015-0309","volume":"21","author":"A Inno","year":"2016","unstructured":"Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A, et al. Neuroendocrine carcinoma of the breast: current evidence and future perspectives. Oncologist. 2016;21:28\u201332.","journal-title":"Oncologist."},{"key":"9612_CR55","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.5858\/arpa.2016-0364-RS","volume":"141","author":"LE Rosen","year":"2017","unstructured":"Rosen LE, Gattuso P. Neuroendocrine tumors of the breast. Arch Pathol Lab Med. 2017;141:1577\u201381.","journal-title":"Arch Pathol Lab Med"},{"key":"9612_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.anndiagpath.2018.11.002","volume":"38","author":"R Terlevi\u0107","year":"2019","unstructured":"Terlevi\u0107 R, Peri\u0107 Balja M, Tomas D, Skenderi F, Kru\u0161lin B, Vranic S, et al. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer. Ann Diagn Pathol. 2019;38:62\u20136.","journal-title":"Ann Diagn Pathol"},{"key":"9612_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10549-005-2414-0","volume":"92","author":"U Kumar","year":"2005","unstructured":"Kumar U, Grigorakis SI, Watt HL, Sasi R, Snell L, Watson P, et al. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1\u20135 and correlation with receptor protein expression and tumor pathology. Breast Cancer Res Treat. 2005;92:175\u201386.","journal-title":"Breast Cancer Res Treat"},{"key":"9612_CR58","first-page":"3997","volume":"34","author":"A Frati","year":"2014","unstructured":"Frati A, Rouzier R, Lesieur B, Werkoff G, Antoine M, Rodenas A, et al. Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. Anticancer Res. 2014;34:3997\u20134003.","journal-title":"Anticancer Res"},{"key":"9612_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-016-3867-z","volume":"158","author":"B McCullar","year":"2016","unstructured":"McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein K, et al. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016;158:195\u2013202.","journal-title":"Breast Cancer Res Treat"},{"key":"9612_CR60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/00000478-200009000-00006","volume":"24","author":"SJ Shin","year":"2000","unstructured":"Shin SJ, DeLellis RA, Ying L, Rosen PP. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24:1231\u20138.","journal-title":"Am J Surg Pathol"},{"key":"9612_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","volume":"472","author":"G Kl\u00f6ppel","year":"2018","unstructured":"Kl\u00f6ppel G, La Rosa S. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms [published correction appears in Virchows arch. 2017 Dec 26]. Virchows Arch. 2018;472:341\u20139.","journal-title":"Virchows Arch"},{"key":"9612_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000489902","volume":"107","author":"A Vanoli","year":"2018","unstructured":"Vanoli A, La Rosa S, Miceli E, et al. Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: analysis of 200 cases with extended follow-up. Neuroendocrinology. 2018;107:114\u201326.","journal-title":"Neuroendocrinology."},{"key":"9612_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000444803","volume":"104","author":"A Vanoli","year":"2017","unstructured":"Vanoli A, La Rosa S, Klersy C, et al. Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases. Neuroendocrinology. 2017;104:112\u201325.","journal-title":"Neuroendocrinology."},{"key":"9612_CR64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000334038","volume":"96","author":"F Panzuto","year":"2012","unstructured":"Panzuto F, Campana D, Fazio N, Brizzi MP, Boninsegna L, Nori F, et al. Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology. 2012;96:32\u201340.","journal-title":"Neuroendocrinology."},{"key":"9612_CR65","doi-asserted-by":"publisher","first-page":"527533","DOI":"10.1097\/SLA.0000000000002939","volume":"271","author":"N Brighi","year":"2020","unstructured":"Brighi N, La Rosa S, Rossi G, et al. Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study. Ann Surg. 2020;271:527533.","journal-title":"Ann Surg"},{"key":"9612_CR66","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/pbc.25823","volume":"63","author":"G de Lambert","year":"2016","unstructured":"de Lambert G, Lardy H, Martelli H, Orbach D, Gauthier F, Gu\u00e9rin F. Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective French multicenter study of 114 cases. Pediatr Blood Cancer. 2016;63:598\u2013603.","journal-title":"Pediatr Blood Cancer"},{"key":"9612_CR67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/SLA.0000000000002736","volume":"270","author":"B Rault-Petit","year":"2019","unstructured":"Rault-Petit B, Do Cao C, Guy\u00e9tant S, Guimbaud R, Rohmer V, Juli\u00e9 C, et al. Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a National Study from the French Group of Endocrine Tumors (GTE). Ann Surg. 2019;270:165\u201371.","journal-title":"Ann Surg"},{"key":"9612_CR68","doi-asserted-by":"publisher","first-page":"99541","DOI":"10.18632\/oncotarget.20362","volume":"8","author":"A Mehrvarz Sarshekeh","year":"2017","unstructured":"Mehrvarz Sarshekeh A, Advani S, Halperin DM, Conrad C, Shen C, Yao JC. Dasari a regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis. Oncotarget. 2017;8:99541\u201351.","journal-title":"Oncotarget."},{"key":"9612_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000333035","volume":"95","author":"J Jernman","year":"2012","unstructured":"Jernman J, Valimaki MJ, Louhimo J, Haglund C, Arola J. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Neuroendocrinology. 2012;95:317\u201324.","journal-title":"Neuroendocrinology."},{"key":"9612_CR70","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4143\/crt.2014.238","volume":"47","author":"JH Sohn","year":"2015","unstructured":"Sohn JH, Cho MY, Park Y, et al. Prognostic significance of defining l-cell type on the biologic behavior of rectal neuroendocrine tumors in relation with pathological parameters. Cancer Res Treat. 2015;47:813\u201322.","journal-title":"Cancer Res Treat"},{"key":"9612_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000443166","volume":"103","author":"JK Ramage","year":"2016","unstructured":"Ramage JK, De Herder WW, Delle Fave G, et al. ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:139\u201343.","journal-title":"Neuroendocrinology."},{"key":"9612_CR72","first-page":"323","volume":"429","author":"S La Rosa","year":"1996","unstructured":"La Rosa S, Sessa F, Capella C, Riva C, Leone BE, Klersy C, et al. Solcia E. Prognostic criteria in nonfunctioning pancreatic endocrine tumours Virchows Arch. 1996;429:323\u201333.","journal-title":"Prognostic criteria in nonfunctioning pancreatic endocrine tumours Virchows Arch"},{"key":"9612_CR73","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0046-8177(96)90303-2","volume":"27","author":"G Pelosi","year":"1996","unstructured":"Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol. 1996;27:1124\u201334.","journal-title":"Hum Pathol"},{"key":"9612_CR74","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/jnci\/djs208","volume":"104","author":"G Rindi","year":"2012","unstructured":"Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Nat Cancer Inst. 2012;104:764\u201377.","journal-title":"J Nat Cancer Inst"},{"key":"9612_CR75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000494355","volume":"107","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, et al. Competitive testing the WHO 2010 vs the WHO 2017 grading of pancreas neuroendocrine neoplasia: data from a large international cohort study. Neuroendocrinology. 2018;107:375\u201386.","journal-title":"Neuroendocrinology."},{"key":"9612_CR76","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00428-018-2407-0","volume":"473","author":"J Kwon","year":"2018","unstructured":"Kwon J, Kim HJ, Park DH, et al. Incidentally detected pancreatic neuroendocrine microadenoma with lymph node metastasis. Virchows Arch. 2018;473:649\u201353.","journal-title":"Virchows Arch"},{"key":"9612_CR77","volume-title":"WHO classification of tumours of the urinary system and male genital organs","author":"H Moch","year":"2016","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2016."},{"key":"9612_CR78","volume-title":"WHO classification of tumours of the female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of the female reproductive organs. Lyon: IARC Press; 2014."},{"key":"9612_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1066896909359914","volume":"18","author":"N Buza","year":"2010","unstructured":"Buza N, Cohen PJ, Hui P, Parkash V. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder. Int J Surg Pathol. 2010;18:94\u2013102.","journal-title":"Int J Surg Pathol"},{"key":"9612_CR80","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/PAI.0000000000000221","volume":"24","author":"L Verduin","year":"2016","unstructured":"Verduin L, Mentrikoski MJ, Heitz CT, Wick MR. The utility of GATA3 in the diagnosis of urothelial carcinomas with variant morphologic patterns. Appl Immunohistochem Mol Morphol. 2016;24:509\u201313.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9612_CR81","doi-asserted-by":"crossref","unstructured":"Uccella S, Mathias-Guiu X, La Rosa S. Genitourinary neuroendocrine neoplasms. In: Asa SL, La Rosa S, Mete O, editors. The spectrum of neuroendocrine neoplasia. Practical approach to diagnosis, classification and therapy. New York: Springer Cham; 2020. pp. 301-333","DOI":"10.1007\/978-3-030-54391-4_14"},{"key":"9612_CR82","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/00000478-200608000-00008","volume":"30","author":"EF Tamas","year":"2006","unstructured":"Tamas EF. Epstein JI prognostic significance of Paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. Am J Surg Pathol. 2006;30:980\u20135.","journal-title":"Am J Surg Pathol"},{"key":"9612_CR83","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/his.13330","volume":"71","author":"S Prendeville","year":"2017","unstructured":"Prendeville S, Al-Bozom I, Comp\u00e9rat E, Sweet J, Evans AJ, Ben-Gashir M, et al. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? Histopathology. 2017;71:926\u201333.","journal-title":"Histopathology."},{"key":"9612_CR84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","volume":"20","author":"AM Bellizzi","year":"2013","unstructured":"Bellizzi AM. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol. 2013;20:285\u2013314.","journal-title":"Adv Anat Pathol"},{"key":"9612_CR85","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.semdp.2015.09.013","volume":"32","author":"J Koo","year":"2015","unstructured":"Koo J, Dhall D. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy? Semin Diagn Pathol. 2015;32:456\u201368.","journal-title":"Semin Diagn Pathol"},{"key":"9612_CR86","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ijc.30400","volume":"139","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139:2679\u201386.","journal-title":"Int J Cancer"},{"key":"9612_CR87","first-page":"378","volume":"44","author":"KI Alexandraki","year":"2019","unstructured":"Alexandraki KI, Tsoli M, Kyriakopoulos G, Angelousi A, Nikolopoulos G, Kolomodi D, et al. Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin. Minerva Endocrinol. 2019;44:378\u201386.","journal-title":"Minerva Endocrinol"},{"key":"9612_CR88","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","volume":"78","author":"TL Tello","year":"2018","unstructured":"Tello TL, Coggshall K, Yom SS, Yu SS. Merkel cell carcinoma: an update and review: current and future therapy. J Am Acad Dermatol. 2018;78:445\u201354.","journal-title":"J Am Acad Dermatol"},{"key":"9612_CR89","doi-asserted-by":"crossref","unstructured":"Uccella S, Asa SL, Mete O. Metastatic neuroendocrine neoplasms of unknown primary site. In: Asa SL, La Rosa S, Mete O, editors. The spectrum of neuroendocrine neoplasia. Practical approach to diagnosis, classification and therapy. New York: Springer Cham; 2021. pp. 357-387.","DOI":"10.1007\/978-3-030-54391-4_16"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-020-09612-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:10:17Z","timestamp":1628226617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-020-09612-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9612"],"URL":"https:\/\/doi.org\/10.1007\/s11154-020-09612-2","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"2 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}